CA
AMAG

Continental Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Continental Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-57,438
Closed -$1.19M – 163
2014
Q2 		$1.19M Buy
+57,438
New +$1.06M 0.28% 87

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Continental Advisors's AMAG Position: Q3 2014 in Review

Continental Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q3 2014, closing a stake of 57,438 shares — an estimated $1.19M sold.

Continental Advisors first reported a position in AMAG in Q2 2014 and held it in 1 quarter. The position peaked at $1.19M in Q2 2014. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • Continental Advisors reported no remaining AMAG Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Continental Advisors sold 57,438 AMAG Pharmaceuticals shares in Q3 2014, an estimated $1.19M.
  • Continental Advisors first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Continental Advisors's AMAG Pharmaceuticals position peaked at $1.19M in Q2 2014.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on Continental Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.